Metrizamide myelography risk factors: a pseudopsychiatric case presentation.
A case of neurologic sequelae from intrathecal metrizamide is presented. The patient had a convulsion, became comatose, and transiently developed mutism and hemiparesis, with eventual full recovery. Metrizamide is generally safe, but side effects do occur, and they may require clinical attention and follow-up.
D000328:Adult; D003128:Coma / Q000139:chemically induced* / Q000175:diagnosis; D003291:Conversion Disorder / Q000175:diagnosis*; D003937:Diagnosis, Differential; D005260:Female; D006429:Hemiplegia / Q000139:chemically induced / Q000175:diagnosis; D006801:Humans; D008793:Metrizamide / Q000009:adverse effects*; D009155:Mutism / Q000139:chemically induced / Q000175:diagnosis; D009192:Myelography; D012640:Seizures / Q000139:chemically induced* / Q000175:diagnosis
D008793:Metrizamide